Skip to main content
. 2019 Dec 4;9:18345. doi: 10.1038/s41598-019-54789-5

Figure 1.

Figure 1

Dose Response Curve – Levodopa Intravitreal Injections. (A) Axial length after four days of treatment for each of the tested conditions. (B) Percent protection against the axial elongation associated with diffuser wear (FD) relative to levodopa concentration administered. (C) Refractive values after four days of treatment for each of the tested conditions. (D) Percent protection against the myopic refractive shift associated with FD relative to levodopa concentration administered. Data represent mean ± standard error of the mean. FD: Form deprivation. Untreated controls: age-matched untreated controls. Statistics denote difference to FD Only; *p < 0.05, **p < 0.02, ***p < 0.001.